Cut taxes, spend AND a trade war? It took a leap of faith,

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks wowhappens28 #24649
415
Cut taxes, spend AND a trade war? It took a leap of faith, and a childlike belief in supply side 'economics,' to not see this coming.

Oh well, an incoming Dem admin will do what the last two did; dig us out of yet another GOP induced recession and give us another bull market. Wash, rinse, repeat.



Stocks tank as another recession warning surfaces



Source: Washington Post

U.S. stocks tumbled at open Wednesday after the inverted yield curve, one of the most reliable indicators of a recession, sparked a new wave of investor fears, erasing the short-lived bump from Tuesday’s trade easing.

For the first time since 2007, the yields on short-term U.S. bonds eclipsed those of long-term bonds. This phenomenon, which suggests investors’ faith in the economy is faltering, has preceded every recession in the last 50 years.

Recessions typically come within 18 to 24 months after the yield curve inverts, according to research from Credit Suisse. “The 3-month Treasury bill to 10-year note curve has been inverted for weeks now and with the inversion of the 2-year to 10-year curve.

The stars are aligned across the curve that the economy is headed for a big fall,” said Chris Rupkey, chief financial economist at MUFG Union Bank. “The yield curves are all crying timber that a recession is almost a reality, and investors are tripping over themselves to get out of the way.”

The Dow Jones industrial average slumped nearly 400 points at open Wednesday, a day after it notched its best performance in two months. The Standard & Poor’s 500 index was down more than 1.4 percent and the tech-heavy Nasdaq was down more than 1.6 percent. Bank stocks slumped off the news.

Bank of America and Citigroup saw their shares sink more than 3 percent and JP Morgan’s shares fell 2.6 percent. Gold, a safe-haven for investors, rose. And the influx of investors scrambling for safety pushed U.S. 30-year Treasury yields to their lowest level ever.

Darkening skies overseas gave investors more to worry about. Germany announced Wednesday that its economy had shrunk, blaming the drop-off on the fallout from the U.S.-China trade war and the looming threat of a hard Brexit.

The European Stoxx 600 benchmark was down nearly 6 percent in midday trading. China reported more signs of a weakening economy Wednesday, with high unemployment and lower production and investment markers, fanning the flames of fears about a broader global slowdown as the protracted trade conflict appears to be stalling some of the world’s most powerful economies.


Read more: https://www.washingtonpost.com/business/2019/...-surfaces/



Original article and headline -


U.S. markets tumble after key indicator triggers recession worries

By Washington Post Staff
August 14 at 9:30 AM

All major stock indexes sank after the yield on the 10-year Treasury bond fell below the rate on the 2-year Treasury bond.

This phenomenon, known as an inverted yield curve, has been a reliable, early indicator of a recession. It last occurred before the 2008 Great Recession.

This is a developing story. It will be updated.

https://www.washingtonpost.com/news/business/...n-worries/



From Marketwatch this morning -

The U.S. Treasury 2-10 year yield curve inverted and that means stocks are on 'borrowed time,' says BAML

Published: Aug 14, 2019 6:58 a.m. ET

The U.S. 2-year Treasury note yield TMUBMUSD02Y, -4.62% traded above the 10-year note yield TMUBMUSD10Y, -5.75% for the first time in over a decade early Wednesday, reinforcing recession worries.

The flattening of the main measure of the U.S. Treasury yield curve already spelled trouble for stock-market investors that have been on the back foot from escalating geopolitical concerns and simmering trade tensions, analysts at Bank of America Merrill Lynch said in a Tuesday note ahead of the inversion.

The inversion of the main measure of the yield curve, or a negative spread between short-term and long-term yields, means a recession indicator is flashing red. " The equity market is on borrowed time after the yield curve inverts," the BAML strategists wrote.

The yield on the 10-year Treasury note was down 5.7 basis points at 1.619%, according to FactSet, while the 2-year yield was off 4.1 basis points at 1.628%.

An inverted yield curve often serves as a prelude to a recession because it indicates when monetary policy and financial conditions are too tight for the broader economy. A yield curve inversion along the 2-year/10-year spread has come before the last seven recessions.

Still, the widely varying lag times between an inversion and an economic downturn makes it difficult to say if an inverted curve points to an imminent slowdown in growth.

Other yield curve measures have already inverted this year. Since May, the 3-month/10-year spread measure utilized by the New York Federal Reserve to analyze recession probabilities has been mostly stuck in negative territory. But investors had previously pointed to the lack of an inversion on the 2-year/10-year spread as a sign that the bond-market was not pointing to a shuddering halt to economic growth.

Rather, it suggested hopes that the Federal Reserve would secure a soft-landing for a U.S. economy through "insurance" interest rate cuts.

https://www.marketwatch.com/story/the-us-trea...o_homepage



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading